Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
4.240
+0.180 (4.43%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Kezar Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 41.75 | 35.49 | 40.46 | 62.88 | 21.23 | Upgrade
|
| Short-Term Investments | 90.5 | 165.88 | 236.11 | 145.47 | 119.22 | Upgrade
|
| Cash & Short-Term Investments | 132.25 | 201.37 | 276.56 | 208.36 | 140.45 | Upgrade
|
| Cash Growth | -34.33% | -27.19% | 32.73% | 48.35% | 79.59% | Upgrade
|
| Other Receivables | 0.42 | 2.29 | 0.77 | - | 0.77 | Upgrade
|
| Receivables | 0.42 | 2.29 | 0.77 | - | 0.77 | Upgrade
|
| Prepaid Expenses | 1.09 | 1.22 | 1.12 | 2.57 | 2.73 | Upgrade
|
| Other Current Assets | 3.73 | 2.07 | 7.27 | 0.73 | 0.87 | Upgrade
|
| Total Current Assets | 137.49 | 206.95 | 285.72 | 211.65 | 144.81 | Upgrade
|
| Property, Plant & Equipment | 4.78 | 8.69 | 13.17 | 6 | 6.75 | Upgrade
|
| Other Long-Term Assets | 2.42 | 5.6 | 0.67 | 0.28 | 0.28 | Upgrade
|
| Total Assets | 144.68 | 221.24 | 299.57 | 217.93 | 151.84 | Upgrade
|
| Accounts Payable | 3.65 | 8.25 | 2.48 | 2.03 | 2.36 | Upgrade
|
| Accrued Expenses | 7.94 | 6.48 | 5.95 | 4.99 | 3.04 | Upgrade
|
| Current Portion of Long-Term Debt | 5.22 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 3.53 | 3.01 | 2.57 | 1.2 | 1.04 | Upgrade
|
| Total Current Liabilities | 20.33 | 17.74 | 11 | 8.21 | 6.44 | Upgrade
|
| Long-Term Debt | 5.11 | 10.07 | 9.83 | 9.62 | - | Upgrade
|
| Long-Term Leases | 2.33 | 5.85 | 8.87 | 3.22 | 4.42 | Upgrade
|
| Total Liabilities | 27.77 | 33.67 | 29.7 | 21.06 | 10.86 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.07 | 0.06 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 551.57 | 538.46 | 519.62 | 377.77 | 267.09 | Upgrade
|
| Retained Earnings | -434.5 | -350.76 | -248.89 | -180.65 | -126.02 | Upgrade
|
| Comprehensive Income & Other | -0.16 | -0.13 | -0.92 | -0.29 | -0.14 | Upgrade
|
| Total Common Equity | 116.92 | 187.57 | 269.87 | 196.88 | 140.98 | Upgrade
|
| Shareholders' Equity | 116.92 | 187.57 | 269.87 | 196.88 | 140.98 | Upgrade
|
| Total Liabilities & Equity | 144.68 | 221.24 | 299.57 | 217.93 | 151.84 | Upgrade
|
| Total Debt | 16.18 | 18.93 | 21.26 | 14.04 | 5.46 | Upgrade
|
| Net Cash (Debt) | 116.07 | 182.44 | 255.3 | 194.31 | 134.98 | Upgrade
|
| Net Cash Growth | -36.38% | -28.54% | 31.39% | 43.95% | 87.89% | Upgrade
|
| Net Cash Per Share | 15.92 | 25.15 | 37.90 | 36.83 | 30.68 | Upgrade
|
| Filing Date Shares Outstanding | 7.31 | 7.28 | 7.08 | 5.67 | 4.81 | Upgrade
|
| Total Common Shares Outstanding | 7.3 | 7.28 | 6.85 | 5.63 | 4.64 | Upgrade
|
| Working Capital | 117.16 | 189.21 | 274.73 | 203.44 | 138.37 | Upgrade
|
| Book Value Per Share | 16.01 | 25.77 | 39.40 | 34.99 | 30.41 | Upgrade
|
| Tangible Book Value | 116.92 | 187.57 | 269.87 | 196.88 | 140.98 | Upgrade
|
| Tangible Book Value Per Share | 16.01 | 25.77 | 39.40 | 34.99 | 30.41 | Upgrade
|
| Machinery | 5.85 | 5.84 | 4.67 | 3.67 | 2.91 | Upgrade
|
| Leasehold Improvements | 3.49 | 3.49 | 3.37 | 3.27 | 3.27 | Upgrade
|
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.